CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
CXCL10 |
P02778
|
C-X-C motif chemokine ligand 10
|
Signaling
|
0.37 |
0.378 |
0.885 |
CXCL8 |
P10145
|
C-X-C motif chemokine ligand 8
|
Signaling
|
2.7E-04 |
0.310 |
0.962 |
CYP2E1 |
P05181
|
cytochrome P450 family 2 subfamily E member 1
|
|
8.1E-09 |
0.459 |
0.885 |
FOXP3 |
Q9BZS1
|
forkhead box P3
|
|
0.99 |
0.368 |
0.846 |
GATA2 |
P23769
|
GATA binding protein 2
|
|
0.98 |
0.496 |
0.654 |
GSTK1 |
Q9Y2Q3
|
glutathione S-transferase kappa 1
|
|
1.9E-06 |
0.412 |
0.885 |
GSTM1 |
P09488
|
glutathione S-transferase mu 1
|
|
2.1E-03 |
0.380 |
0.923 |
GSTT1 |
P30711
|
glutathione S-transferase theta 1
|
|
1.5E-04 |
0.393 |
0.923 |
HAVCR2 |
Q8TDQ0
|
hepatitis A virus cellular receptor 2
|
|
3.9E-02 |
0.450 |
0.808 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
HPGDS |
O60760
|
hematopoietic prostaglandin D synthase
|
|
1.8E-06 |
0.388 |
0.923 |
IL17A |
Q16552
|
interleukin 17A
|
|
4.3E-02 |
0.324 |
0.923 |
IL18 |
Q14116
|
interleukin 18
|
|
3.1E-02 |
0.365 |
0.923 |
IL1A |
P01583
|
interleukin 1 alpha
|
|
1.6E-04 |
0.333 |
0.962 |
IL2 |
P60568
|
interleukin 2
|
|
0.48 |
0.336 |
0.885 |
IL21 |
Q9HBE4
|
interleukin 21
|
|
0.63 |
0.441 |
0.769 |
IL22 |
Q9GZX6
|
interleukin 22
|
|
1.9E-04 |
0.393 |
0.885 |
IL2RA |
P01589
|
interleukin 2 receptor subunit alpha
|
Receptor
|
5.5E-02 |
0.389 |
0.885 |
ISG20 |
Q96AZ6
|
interferon stimulated exonuclease gene 20
|
|
2.9E-03 |
0.414 |
0.846 |
SLCO6A1 |
Q86UG4
|
solute carrier organic anion transporter family member 6A1
|
Transporter
|
2.9E-11 |
0.412 |
0.885 |
TGFB1 |
P01137
|
transforming growth factor beta 1
|
Signaling
|
3.7E-02 |
0.287 |
0.962 |
TNF |
P01375
|
tumor necrosis factor
|
Signaling
|
0.80 |
0.231 |
0.962 |